Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Caculate the PTSC value Ometepan

RE: Caculate the PTSC value Ometepan

posted on Apr 20, 2006 03:22PM
There is no exact formula to determine value. The market will determine the value based on what stage of development this company is at, market perceptions/press accounts and general sector bias...hence the potential for more dramatic moves on news of major changes taking place.

It`s not hype. We have just witnessed it and it`s very real. Can it continue? Yes, given they continue to land licensing deals of equal or greater magnitude and management has a plan for the money beyond dividend give aways.

This current growth phase may be sustained or grow even faster, both good scenarios for ptsc shareholders. However, another possibility is management getting proactive and doing something with the capital to further enhance shareholder value (acquisitions).

It`s very hard to place value by tradition methods at these very early stages. Don`t cut yourself short and don`t get greedy...both easier said than done.

Then there is the NASDAQ factor, which will be the next target should this exponential growth curve continue, and which will expose ptsc to an entire new group of investors.

PTSC is well on its way.

Share
New Message
Please login to post a reply